Viking Therapeutics stock jumps 120% after positive weight loss drug trial results – CNBC By Weight Loss Viking Therapeutics stock jumps 120% after positive weight loss drug trial results CNBC Viking Therapeutics’ stock doubles after company reports positive results in trial of weight-loss drug MarketWatch Viking Therapeutics notches success with weight-loss drug trial, shares double Reuters Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest